Targeting HIF-1 for cancer therapy
Gregg L. Semenza · Nature reviews. Cancer · 2003
Cited by 6,698 works. doi:10.1038/nrc1187
Authors
References
- Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.
- The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
- Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O 2 -Regulated Prolyl Hydroxylation
- HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
- A Nuclear Factor Induced by Hypoxia via De Novo Protein Synthesis Binds to the Human Erythropoietin Gene Enhancer at a Site Required for Transcriptional Activation
- Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
- Hypoxia — a key regulatory factor in tumour growth
- Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
- C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation